Zacks.com on MSN13h
AKRO Stock Doubles in a Week as Lead Drug Meets Goal in MASH Study
Akero stock soars 106% in a week following initial positive top line 96-week data from a mid-stage MASH study of its lead ...
Geneos Wealth Management Inc. Has $502,000 Stock Holdings in Galectin Therapeutics Inc. (NASDAQ:GALT)
Geneos Wealth Management Inc. raised its stake in Galectin Therapeutics Inc. (NASDAQ:GALT – Free Report) by 10.2% in the 4th ...
David Lebowitz’s Buy Recommendation for Madrigal Pharmaceuticals Amid Positive Outlook and Promising Future Prospects
Citi analyst David Lebowitz has maintained their bullish stance on MDGL stock, giving a Buy rating yesterday.Invest with Confidence: Follow ...
Knowridge5h
Diabetes and obesity can damage the liver to the point of failure – but few people know their risk of developing liver disease
Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...
Dose-dependent link seen for alcohol, cirrhosis, liver cancer in patients with hepatitis B
For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and ...
Scientists Discover Game-Changing Therapy to Combat High Cholesterol
Scientists have discovered a potential new treatment for familial hypercholesterolemia, inspired by signs seen in the Mona ...
FDA approves Ozempic for diabetes patients to cut kidney disease risk
The FDA approval is based on results from a trial investigating the effects of once-a-week Ozempic injections on major kidney ...